Kcm Investment Advisors LLC Pfizer Inc Transaction History

Kcm Investment Advisors LLC

$2.76 Billion
Q2 2024

A detailed history of Kcm Investment Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Kcm Investment Advisors LLC holds 136,103 shares of PFE stock, worth $3.94 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

136,103

Previous 143,467 5.13%

Holding current value

$3.94 Million

Previous $3.98 Million 4.35%

% of portfolio

0.14%

Previous 0.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$25.26 - $29.6 $186,014 - $217,974	-7,364 Reduced 5.13%	136,103 $3.81 Million
Q1 2024 May 07, 2024	BUY	$25.89 - $29.73 $88,828 - $102,003	3,431 Added 2.45%	143,467 $3.98 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $480,373 - $623,952	-18,384 Reduced 11.6%	140,036 $4.03 Million
Q3 2023 Nov 08, 2023	SELL	$32.09 - $37.51 $430,904 - $503,684	-13,428 Reduced 7.81%	158,420 $5.25 Million
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $243,773 - $282,040	-6,749 Reduced 3.78%	171,848 $6.3 Million
Q1 2023 May 09, 2023	SELL	$39.39 - $51.28 $293,100 - $381,574	-7,441 Reduced 4.0%	178,597 $7.29 Million
Q4 2022 Jan 31, 2023	SELL	$41.75 - $54.5 $1.57 Million - $2.04 Million	-37,512 Reduced 16.78%	186,038 $9.53 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $383,468 - $468,119	-8,763 Reduced 3.77%	223,550 $9.78 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $117,860 - $139,745	-2,533 Reduced 1.08%	232,313 $12.2 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $1.78 Million - $2.2 Million	-38,842 Reduced 14.19%	234,846 $12.2 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $2.27 Million - $3.37 Million	54,972 Added 25.13%	273,688 $16.2 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $139,219 - $178,839	-3,547 Reduced 1.6%	218,716 $9.41 Million
Q2 2021 Oct 21, 2021	BUY	$35.91 - $40.68 $20,648 - $23,391	575 Added 0.26%	222,263 $8.7 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $122,273 - $138,515	3,405 Added 1.56%	221,688 $8.68 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $233,358 - $263,181	6,968 Added 3.3%	218,283 $7.91 Million
Q4 2020 Feb 19, 2021	BUY	$33.47 - $42.56 $1.53 Million - $1.94 Million	45,594 Added 27.51%	211,315 $7.78 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $834,580 - $979,153	-26,286 Reduced 13.69%	165,721 $6.08 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $539,027 - $653,919	17,896 Added 10.28%	192,007 $6.28 Million
Q1 2020 Apr 27, 2020	BUY	$27.03 - $38.62 $637,232 - $910,466	23,575 Added 15.66%	174,111 $5.68 Million
Q4 2019 Feb 18, 2020	SELL	$32.92 - $37.36 $174,080 - $197,559	-5,288 Reduced 3.39%	150,536 $5.9 Million
Q3 2019 Nov 15, 2019	SELL	$32.49 - $42.13 $162,352 - $210,523	-4,997 Reduced 3.11%	155,824 $5.6 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $257,158 - $288,730	6,954 Added 4.52%	160,821 $6.97 Million
Q1 2019 May 16, 2019	SELL	$37.5 - $41.2 $139,612 - $153,387	-3,723 Reduced 2.36%	153,867 $6.54 Million
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $47,087 - $53,684	1,224 Added 0.78%	157,590 $6.88 Million
Q3 2018 Nov 07, 2018	SELL	$34.47 - $41.81 $113,233 - $137,345	-3,285 Reduced 2.06%	156,366 $0
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $2.6 Million - $2.77 Million	-78,751 Reduced 33.03%	159,651 $5.79 Million
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $763,702 - $885,999	-23,933 Reduced 9.12%	238,402 $8.46 Million
Q4 2017 Feb 22, 2018	SELL	$33.26 - $35.29 $120,866 - $128,243	-3,634 Reduced 1.37%	262,335 $9.5 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $8.25 Million - $9.08 Million	265,969	265,969 $9.5 Million

Others Institutions Holding PFE

# of Institutions

3,222

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $162B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kcm Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kcm Investment Advisors LLC with notifications on news.

Account

Kcm Investment Advisors LLC Pfizer Inc Transaction History